Maravai LifeSciences | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Maravai LifeSciences Holdings, Inc.
Industry & Market
Funding Information
Headcount Distribution
By Department
Department Breakdown
Keywords & Focus Areas
Overview
Maravai LifeSciences Holdings, Inc. is a prominent life sciences company providing products and services to advance the development of vaccines, drug therapies, diagnostics, and research on human diseases. With over 35 years of expertise, the organization specializes in nucleotide research and is a recognized leader in the mRNA market. It offers high-quality solutions and expert support to biotech and biopharma clients.
The company’s portfolio spans complex nucleic acids for vaccines and therapeutics, custom enzymes for research, and antibody-based products for impurity detection. Key brands include TriLink BioTechnologies, Glen Research, Cygnus Technologies, and Alphazyme. Maravai emphasizes mRNA solutions for oncology, infectious diseases, and pandemic response, enabling reliable scale-up and supply chain capabilities. Its commitment is to empower scientists, serving global biopharmaceutical leaders and academic institutions.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to Maravai LifeSciences
Compare insights from companies similar to Maravai LifeSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxx | $53988 | 132 | Private | - | 5985 | xxxxxx |
| xxxxxx | $69556 | 66 | Private | - | 3900 | xxxx |
| xx | $73070 | 86 | Private | - | 4898 | xx |
| xxxxxxxxxx | $47654 | 14 | Private | - | 6796 | xx |
| xxxxxxxx | $60593 | 93 | Private | - | 2027 | xxxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.